SCHEMBL19976972

SCHEMBL19976972

CCCOc1ccccc1NC(=O)C(C)NC(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.59
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
KMT2A Q03164 4/20 0.51
KDM4E B2RXH2 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
LMNA P02545 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
PKM P14618 1/20 0.50
HTT P42858 1/20 0.50
NLRP1 Q9C000 1/20 0.50
TSHR P16473 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
MEN1 O00255 2/20 0.46
MRGPRX1 Q96LB2 1/20 0.46
POLB P06746 1/20 0.46
CREBBP Q92793 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976899 0.86 KMT2A (0.49) GAANPC1RAB9AKMT2AKDM4E
SCHEMBL16999308 0.84 GAA (0.55) GAANPC1RAB9AKMT2AL3MBTL1
SCHEMBL19976980 0.83 NPC1 (0.66) NPC1RAB9AKMT2ALMNAALDH1A1
SCHEMBL19976971 0.82 HDAC1 (0.53) NPC1RAB9AKMT2AKDM4EL3MBTL1
SCHEMBL19977138 0.81 HPGD (0.48) GAARAB9AKMT2AL3MBTL1LMNA
SCHEMBL19976893 0.80 SMN1; SMN2 (0.60) NPC1RAB9AKMT2AHTTTSHR
SCHEMBL19977069 0.79 ALDH1A1 (0.57) RAB9AL3MBTL1LMNAALDH1A1MAPT
SCHEMBL16119627 0.78 EPHX1 (0.62) GAANPC1RAB9AKMT2AKDM4E
SCHEMBL19976970 0.77 NPC1 (0.53) NPC1RAB9AKMT2ALMNAALDH1A1
SCHEMBL19976922 0.76 HPGD (0.66) GAANPC1RAB9AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9919998-B2 Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2018-03-20 US disclosed